NewGenIvf (NIVF) EBIT (2024 - 2025)
NewGenIvf (NIVF) reported EBIT of -$5.0 million for Q4 2025, down 356.66% year-over-year from $1.9 million in Q4 2024, and down 97.95% quarter-over-quarter from -$2.5 million in Q3 2025.
NewGenIvf (NIVF) EBIT (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has 2 years of EBIT data on file, last reported at -$5.0 million in Q4 2025.
- EBIT for Q4 2025 came in at -$5.0 million, down 356.66% year-over-year; the trailing twelve-month figure through Dec 2025 was -$8.4 million (changed N/A YoY), and the FY2025 annual result was -$10.7 million, down 824.3% from the prior year.
- EBIT slipped to -$5.0 million in Q4 2025 per NIVF's latest filing, from -$2.5 million in the prior quarter.
- Over five years, EBIT peaked at $216311.0 in Q3 2024 and troughed at -$5.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -566.00 Mn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 1.30 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 481.89 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 59.70 Mn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 124.85 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 502.86 Mn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 2.13 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 84.58 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 120.04 Mn |
| 10 | NewGenIvf | - | - | 524,025.00 | -4.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.97 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Dec 31, 2024 | -1.09 Mn |
| Sep 30, 2024 | 216,311.00 |